Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Komen(R) , the world's leading breast cancer organization, commends Representative Rick Scarbrough (R-Oak Ridge) and Senator Richard Briggs (R-Knoxville) for introducing legislation that would ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands ...